Thomas Finne's Insider Trades & SAST Disclosures
Thomas Finne's most recent trade in Anika Therapeutics Inc. was a trade of 2,548 Common Stock done . Disclosure was reported to the exchange on March 9, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas Finne.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,548 | 25,346 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 2,548 | 5,097 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.22 per share. | 09 Mar 2022 | 748 | 24,598 (0%) | 0% | 26.2 | 19,613 | Common Stock |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,000 | 0 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,000 | 23,679 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,834 | 21,511 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 2,834 | 2,833 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 25 Feb 2022 | 881 | 22,798 (0%) | 0% | 32.1 | 28,307 | Common Stock |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.13 per share. | 25 Feb 2022 | 832 | 20,679 (0%) | 0% | 32.1 | 26,732 | Common Stock |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,638 | 62,531 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 1,515 | 60,893 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 1,593 | 59,378 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Sale of securities on an exchange or to another person at price $ 14.99 per share. | 27 May 2021 | 5,000 | 57,785 (0%) | 0% | 15.0 | 74,965 | Common Shares |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 1,693 | 62,785 (0%) | 0% | 0 | Common Shares | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 19,158 | 19,158 | - | - | Stock Option (Right to Buy) | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 7,645 | 7,645 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 3,000 | 12,582 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 3,000 | 3,000 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 2,833 | 5,667 | - | - | Restricted Stock Unit | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 2,833 | 10,414 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.57 per share. | 25 Feb 2021 | 881 | 11,701 (0%) | 0% | 37.6 | 33,099 | Common Stock |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.39 per share. | 25 Feb 2021 | 832 | 9,582 (0%) | 0% | 37.4 | 31,108 | Common Stock |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 2,030 | 61,092 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2020 | 2,718 | 59,062 (0%) | 0% | 0 | Common Shares | |
| Anika Therapeutics Inc. | Thomas Finnerty | EVP Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.62 per share. | 30 Oct 2020 | 666 | 7,581 (0%) | 0% | 32.6 | 21,725 | Common Stock |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 3,102 | 56,344 (0%) | 0% | 0 | Common Shares | |
| SITE Centers Corp | Thomas Finne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 5,377 | 53,242 (0%) | 0% | 0 | Common Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges